SCYNEXIS, Inc.
P.O. Box 12878
Research Triangle Park
North Carolina
27709
United States
Tel: 919-544-8600
Fax: 919-544-8697
Website: http://www.scynexis.com/
Email: terry.marquardt@scynexis.com
288 articles with SCYNEXIS, Inc.
-
SCYNEXIS, Inc. Receives Merial Research Collaboration Milestone Payment
12/13/2007
-
SCYNEXIS, Inc. and DNDi Enter Landmark Multi-Year Agreement to Identify Drug Candidates to Treat Sleeping Sickness
11/5/2007
-
Merial-SCYNEXIS, Inc. Research Collaboration Expanded
5/15/2007
-
SCYNEXIS, Inc. Receives Preclinical Milestone Payment In Collaboration With Merck & Co., Inc.
1/9/2007
-
SCYNEXIS, Inc. Announces Research Agreement With Merck & Co., Inc. For Discovery Of Novel Oncology Agents
12/7/2006
-
SCYNEXIS, Inc. Announces New Board Chairman And New Board Member Appointments Of Well-Known Pharmaceutical Executives
3/27/2006
-
SCYNEXIS Europe, Ltd. Is Now Selcia Following Spin Off From SCYNEXIS, Inc.
1/5/2006
-
Tech Council of Maryland Release: Area Life Science Companies Chosen To Make Presentations For Venture Funding At 2005 Mid-Atlantic Bio
10/12/2005